Healthcare -
Biotechnology - NASDAQ - GB
$ 2.41
0.417 %
$ 74.6 M
Market Cap
-8.03
P/E
MREO - STOCK-BASED COMPENSATION
Stock-based Compensation MREO - Mereo BioPharma Group plc
4.92 M
LAST VALUE
5.11%
2 YEAR CAGR
17.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR